With the rise of personalized medicine, should health insurance companies be allowed to charge higher premiums to individuals predisposed to certain genetic diseases? What are the ethical considerations?

With the rise of personalized medicine, there is debate about whether insurance companies should be allowed to charge higher premiums for people who are genetically at risk of certain diseases. Some people argue this is reasonable because insurance is based on risk, while others think it is unfair. On the one hand, insurance companies need […]